Predicting chemotherapy response in gastric cancer
Part of Cancer, Digestive system clinical trials.
This research study analyzes tumor tissue samples to understand why some patients respond better to chemotherapy after gastric cancer surgery. By studying how genes are processed in cancer cells, researchers hope to predict which patients will benefit most from treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with stage II or III gastric cancer (confirmed by biopsy)
- Had surgery to remove the stomach cancer
- Received chemotherapy after surgery (a type called 5-FU based)
- Tumor tissue sample available for the study to examine
- No history of other types of cancer
- Tissue sample must be good quality and not contaminated
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial uses a combination of CT scans, ultrasound, and blood tests to predict how well chemotherapy will work for people with locally advanced gastric cancer. The goal is to personalize treatment by identifying who will respond best to neoadjuvant chemotherapy.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This trial is for people who have already had chemotherapy and surgery for stomach cancer. It compares different follow-up approaches to see if skipping more chemo after surgery is safe and effective.
This trial tests a computer-based model that uses CT scans, endoscopic images, and biopsy tissue to predict how well stomach cancer will respond to chemotherapy given before surgery. The goal is to help doctors choose the best treatment for each patient.
This study uses special blood tests to detect cancer DNA and help doctors decide the best treatment plan for gastric cancer. The goal is to improve outcomes by personalizing therapy based on how your cancer responds.
Hear when a new Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.